FSH isoform composition of commercial gonadotrophin preparations: A neglected aspect?

Reproductive BioMedicine Online

Volumn 9, Issue 2, 2004, Pages 231-236

  Andersen, Claus Yding ^a   Westergaard, Lars Grabow ^b   van Wely, Madelon ^c  

^a Mental Health Services CPH   (Denmark)

^b The Fertility Clinic Trianglen   (Denmark)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Clinical efficacy; FSH bioactivity; FSH isoform; Gonadotrophin preparation; Meta analysis

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; DRUG STRUCTURE; HORMONE ACTION; HUMAN; META ANALYSIS; OVARY FOLLICLE; PREGNANCY COMPLICATION; REVIEW;

EID: 4344581396     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62135-9     Document Type: Review

References (26)

1. Anobile CJ, Talbot JA, McCann SJ et al. 1998 Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state. Molecular Human Reproduction 4, 631-639.
2. Barrios-De-Tomasi J, Timossi C, Merchant H et al. 2002 Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones. Molecular and Cellular Endocrinology 186, 189-198.
3. Beckers NG, Macklon NS, Devroey P et al. 2003 First live birth after ovarian stimulation using a chimeric long-acting human recombinant follic-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertility and Sterility 79, 621-623.
4. Bergh C, Howles CM, Borg K et al. 1997 Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Human Reproduction 12, 2133-2139.
5. Creus S, Chaia Z, Pellizzari EH 2001 Human FSH isoforms: carbohydrate complexity as determinant of in-vitro bioactivity. Molecular and Cellular Endocrinology 174, 759-768.
6. Daya S 2002 Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertility and Sterility 77, 711-714.
7. Duijkers IJ, Klipping C, Boerrigter PJ, et al. 2002 Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Human Reproduction 17, 1987-1993.
8. Franco JG Jr, Baruffi RL, Coelho J et al. 2000 A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH. Gynecology and Endocrinology 14, 5-10.
9. Frydman R, Howles CM, Truong F 2000 A double-blind, randomized. study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists. Human Reproduction 15, 520-525.
10. Gordon K 2002 New developments in gonadotropin pharmacology. Reproductive BioMedicine Online 5, 259-265.
11. Hard K, Mekking A, Damm JB et al. 1990 Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. European Journal of Biochemistry 193, 263-271.
12. Harris SD, Anobile CJ, McLoughlin JD et al. 1996 Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulation hormone (Puregon, Org 32489): a comparison with Metrodin and Metrodin-HP. Molecular Human Reproduction 2, 807-811.
13. Lambert A, Rodgers M, Mitchell R et al. 1995 In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Human Reproduction 10, 1928-1935.
14. Lenton E, Soltan A, Hewitt J et al. 2000 Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Human Reproduction 15, 1021-1027.
15. Nayudu PL, Vitt UA, Banios-De-Tomasi J et al. 2002 Intact follicle culture: what it can tell us about the roles of FSH glycoforms during follicle development. Reproductive BioMedicine Online 5, 240-253.
16. Robertson WR 1977 Gonadotrophin isoform pattern in different pharmaceutical preparation. In: Kahn J (ed.) Gonadotrophin Isoforms; Facts and Future. Serono Fertility Series vol. 2, pp. 53-60.
17. Rodgers M, Mitchell R, Lambert A et al. 1992 Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clinical Endocrinology 37, 558-564.
18. Rodgers M, McLoughlin JD, Lambert A et al. 1995 Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations. Human Reproduction 10, 1982-1986.
19. Schats R, Sutter PD, Bassil S et al. 2000 Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of the Feronia and Apis study group. Human Reproduction 15, 1691-1697.
20. Ulloa-Aguirre A, Timossi C 2000 Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotropins. Reproductive BioMedicine Online 1, 48-62.
21. Ulloa-Aguirre A, Midgley AR Jr, Beitins IZ, Padmanabhan V 1995 Follicle-stimulating isohormones: characterization and physiological relevance. Endocrine Reviews 16, 765-787.
22. Ulloa-Aguirre A, Timossi C, Barrios-de-Tomasi J et al. 2003 Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models. Biology of Reproduction 69, 379-389.
23. van Wely M, Westergaard LG, Bossuyt PM, van der Veen F 2003 Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertility and Sterility 80, 1086-1093.
24. Wide L, Naessen T 1994 17 Beta-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause. Clinical Endocrinology 40, 783-789
25. Yding Andersen C 2002 Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles. Reproductive BioMedicine Online 5, 234-241.
26. Yding Andersen C, Leonardsen L, Ulloa-Aguirre A et al. 1999 FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms. Mololecular Human Reproduction 5, 726-731.